HIV RNA tests

Published: 30 June 2012
  • Viral load tests are primarily used to monitor disease progression.
  • They can also help diagnose primary (recent) infection.
  • The tests' window periods are short, but false positives are common.
  • They are not routinely used in the UK.

HIV RNA tests are primarily used to monitor progression in people already diagnosed with HIV and provide information about people’s viral loads. They are also commonly used to screen blood donations.

Because HIV RNA is detectable considerably sooner than antibodies, many in the United States are enthusiastic about the potential of RNA testing to help diagnose primary infection.

Rather than run separate for each patients (which would be expensive), the Americans test pooled samples of blood. In other words, samples are stored until there are 90 to test. If the pool tests negative, then all the samples are deemed to be negative. However, if the pool tests positive, then smaller pools of 10 are tested, until each of the samples with HIV are isolated.1

However critics point out that in most settings, it takes several days to accumulate enough samples to be pooled, and that sending samples to a regional centre also incurs delays. In the United States, it typically takes 14 days to get results, which is arguably too long when diagnosing primary infection.

Moreover third-generation tests are still routinely used in the US, and whilst RNA testing may have a strong advantage over those tests, British doctors have tended to argue that RNA testing offers few advantages over fourth-generation tests.

References

  1. Pilcher CD et al. Detection of acute infections during HIV testing in North Carolina. NEJM 352:1873-1883, 2005
This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.